Navigation Links
Delcath Reconfirms Presentation During American Society of Clinical Oncology 2010 Annual Meeting in Chicago
Date:5/19/2010

device company focused on oncology. Delcath's proprietary system for chemosaturation is designed to administer high dose chemotherapy and other therapeutic agents to diseased organs or regions of the body, while controlling the systemic exposure of those agents. The Company's initial focus is on the treatment of primary and metastatic liver cancers.  Delcath recently concluded a Phase III metastatic melanoma study and the Company is currently conducting a multi-arm Phase II trial to treat other liver cancers. For more information, please visit the Company's website at www.delcath.com.

The Private Securities Litigation Reform Act of 1995 provides a safe harbor for forward-looking statements made by the Company or on its behalf. This news release contains forward-looking statements, which are subject to certain risks and uncertainties that can cause actual results to differ materially from those described. Factors that may cause such differences include, but are not limited to, uncertainties relating to the acceptability of the Phase III clinical trial data by the FDA, our ability to successfully complete the new drug application, acceptance of the new drug application by the FDA, approval by the FDA or other regulatory authorities of the current or future drug delivery system for the treatment of metastatic melanoma, our ability to successfully complete other clinical trials and secure regulatory approval of our current or future drug-delivery system for the treatment of other liver cancers and other organs and uncertainties regarding our ability to obtain financial and other resources for any research, development and commercialization activities. These factors, and others, are discussed from time to time in our fili
'/>"/>

SOURCE Delcath Systems, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Delcath Expands Phase III Trial for Metastatic Melanoma to Include University of Maryland Medical Center
2. Delcath Updates Phase III Patient Enrollment as Pivotal Trial Accelerates, Durable Tumor Responses In Phase II Study Also Cited
3. Delcath Expands Phase III Trial for Metastatic Melanoma to Include St. Lukes Cancer Center
4. Delcath Adds Dr. Pamela R. Contag to Its Board of Directors
5. Delcath Continues Expansion of Clinical Trial Centers Offering PHP(TM)
6. Enrollment in Delcaths Pivotal Phase III Metastatic Melanoma Clinical Trial Achieves Seventy-Five Percent Accrual
7. Data Safety Monitoring Board Unanimously Recommends Continuation of Delcaths Phase III Clinical Trial
8. Delcath Systems, Inc. Appoints Dr. Krishna Kandarpa its Executive Vice President R&D and Chief Medical Officer
9. Delcath Systems, Inc. Completes Phase III Study Enrollment
10. Delcath Systems Begins Data Analysis of Phase III Trial
11. Delcath Systems, Inc. to Present at the 12th Annual Needham Growth Stock Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2015)... April 28, 2015   GenSpera, Inc. ... and Trademark Office has issued U.S. Patent No. ... claiming numerous compositions for the company,s prodrugs designed ... GenSpera is developing a series ... powerful cytotoxin isolated from the poisonous plant, ...
(Date:4/28/2015)... , April 28, 2015  Unfors RaySafe, the ... new radiation Survey sensor aimed at expanding the RaySafe ... X2 Survey sensor is the easiest and fastest solution ... It is the latest addition to the continually expanding ... to perform leakage and scatter measurements in diagnostic X-ray ...
(Date:4/28/2015)... 2015 /CNW/ - The group representing the living victims of ... a two-hour meeting with Health Canada officials in a ... Canada announced a $180 million support package for Thalidomide ... after the Health Canada announcement and five months after ... victims, the group representing Canada,s ...
Breaking Medicine Technology:GenSpera Granted New Patent for Prodrugs Activated by Prostate Specific Antigen 2Unfors RaySafe, a Fluke Biomedical company, unveils a new Survey sensor for the RaySafe X2 2Thalidomide Victims Gravely Concerned by Health Canada's Silence 2
... AAHC Calls for National Entity to Address Workforce ... center CEOs told congressional staff and representatives of ... that pending health reform legislation does not yet ... to implement successful health system reform. "Pending ...
... AMN Healthcare Services, Inc. (NYSE: AHS ), the ... its quarterly conference call to discuss third quarter results on ... company also expects to issue an earnings news release on ... approximately 4:00 p.m. Eastern Time. , A live webcast of ...
Cached Medicine Technology:Health Reform Bills Still Lack Strategic Focus on Health Workforce 2AMN Healthcare Services to Host 2009 Third Quarter Earnings Conference Call on Thursday, October 29, 2009 2
(Date:4/28/2015)... 2015 Foundations Recovery Network (FRN), an ... the rebranding of its Memphis based residential treatment facility. ... will now be known as The Oaks at LaPaloma, ... stand of beautiful old Oak trees long regarded for ... be new, the commitment and dedication to helping people ...
(Date:4/27/2015)... April 28, 2015 Medical Device Design ... FDAnews and Ombu Enterprises**, June 16-17, 2015 – Chicago, ... inspector came to a facility today, would the design ... the answer is "maybe" or "no" … then very ... FDAnews have a solution. , Take this important ...
(Date:4/27/2015)... (PRWEB) April 28, 2015 Healthcare ... white paper called “Website Anatomy 101.” ... discusses the necessary design elements for a successful ... on responsive design, user experience, search results and ... impact of a well-designed website on patient volume ...
(Date:4/27/2015)... 27, 2015 A new type of festival ... 9. Science on Tap at the Science Museum of Virginia ... but adds science hops for a bold, new flavor. , ... and serves up the science behind these frothy beverages. Guests ... first-hand look at the ingredients that go into beer with ...
(Date:4/27/2015)... FL (PRWEB) April 27, 2015 Moreno ... http://www.morenoranches.com/ , is proud to announce their "This ... others interested in Brahman cattle breeding and education was ... Venus, Florida, on April 18, 2015. It brought ... cultivate future interest in cattle breeding in general, and ...
Breaking Medicine News(10 mins):Health News:Foundations Recovery Network Rebrands LaPaloma Treatment Center as The Oaks at LaPaloma 2Health News:FDAnews Announces: Medical Device Design Control: Implementing an Approach That Works, June 16-17, Chicago, IL 2Health News:FDAnews Announces: Medical Device Design Control: Implementing an Approach That Works, June 16-17, Chicago, IL 3Health News:FDAnews Announces: Medical Device Design Control: Implementing an Approach That Works, June 16-17, Chicago, IL 4Health News:Smith & Jones Publishes 2015 Website Design White Paper 2Health News:Science on Tap at the Science Museum of Virginia 2Health News:Leading Ranch for Brahman Cattle for Sale, Moreno Ranches, Announces Conclusion of 'This is It' Event for Brahman Juniors. 2
... Expectant mothers who have lower intake of folic acid ... higher chance of having babies with low birth weight ... Tyne, UK, had found that increased levels of folic ... of newborns, and vice versa. ,Researchers have examined ...
... combing of wet hair may be far more effective ... ,Researchers have used single blind randomized controlled trial for ... insecticide treatments against head lice in United Kingdom. , ... effective than current over the counter chemical treatments for ...
... to mothers who have low levels of foliate// in their ... ,Folate is essential for fetal growth and gene expression. ... and maintain new cells. It is a B vitamin and ... ,Women are usually prescribed folic acid supplements, a synthetic ...
... of $7 million for upgrading a medical college in ... Sardar Vallavbhai Patel Postgraduate Institute of Paediatrics (in Cuttack) ... dispensation of healthcare to a wider population," said a ... the project were signed and exchanged here Thursday by ...
... memories of unpleasant experiences with unhealthy foods could be ... Loftus of the University of California, Irvine, and her ... eating strawberry ice cream as a child. , ... about food. The volunteers subsequently received feedback on their ...
... Researchers have developed a portable la-chip called Genotyper that ... within hours and help the doctors to treat patients ... the Genotyper is on its way to become fully ... all around the world to track the various flu ...
Cached Medicine News:Health News:Study Links Folic Acid With Increased Birth Weight 2Health News:Combing Hair More Effective Than OTC Medicine For Head Lice 2Health News:Vitamin Supplements During Pregnancy to Boost Fetal Development 2Health News:Unpleasant Memory of Food could Be Used to Treat Obesity 2Health News:New Tools To Identify Flu Strains 2
... as bone Gla protein, is a vitamin ... major component of the noncollagenous bone matrix ... bone, with a small amount produced by ... During bone formation, newly synthesized osteocalcin is ...
... Human Insulin-like growth factor binding protein-2 (IGFBP-2) ... IGFBPs have been proposed) which specifically bind ... IGF-II. The binding affinity of IGFBP-2 for ... than for IGF-I [1], suggesting a role ...
... produced in the adrenal gland and gonads, ... and estrone, both of which may be ... weak androgenic activity, estimated at ~(less than ... However, serum androstenedione levels often exceed testosterone ...
... Inhibins are heterodimeric proteins that suppress ... from the pituitary. Inhibin consists of two ... linked together. Inhibin A consists of the ... the alpha-subunit and betaB-subunit. Only the dimeric ...
Medicine Products: